Dose to pelvic lymph nodes in locally advanced cervical cancer during high-dose-rate brachytherapy with tandem-ring applicators (original) (raw)
Equivalent dose in 2 Gy (EQD2) to pelvic lymph nodes using volume based prescription for three brachytherapy applicators — a dosimetric retrospective analysis
Ram Alva
Reports of Practical Oncology and Radiotherapy, 2021
View PDFchevron_right
Three-dimensional dosimetric considerations from different point A definitions in cervical cancer low-dose-rate brachytherapy
Venkat Narra
Journal of Contemporary Brachytherapy, 2013
View PDFchevron_right
Image guided adaptive brachytherapy for cervical cancer: dose contribution to involved pelvic nodes in two cancer centers
Laura Velema
Journal of Contemporary Brachytherapy, 2014
View PDFchevron_right
Dosimetric Analysis and Effect of Different Definitions of Prescription Point “A” to OAR in High Dose Rate Brachytherapy for Cervical Cancer
Shivangi Agrawal
Asian Pacific Journal of Cancer Care
View PDFchevron_right
Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study
jamema swamidas
International Journal of Radiation Oncology*Biology*Physics, 2020
View PDFchevron_right
Positional variation of applicators during low dose rate intracavitary brachytherapy for cervical cancer: a prospective study
Arul Ponni
DOAJ (DOAJ: Directory of Open Access Journals), 2010
View PDFchevron_right
Clinical Investigations Evaluation of variation in dose of organs at risk in intracavitary brachytherapy of cervical cancer – a prospective study
Brahmacharimayum Nelson Sharma
Journal of Contemporary Brachytherapy
View PDFchevron_right
Dose Variation To Critical Points In Low Dose Rate Intracavitary Brachytherapy Of Cervical Cancer As Justification For Incident Learning
Francis Hasford
European Scientific Journal, ESJ, 2022
View PDFchevron_right
Dosimetric changes and interfraction anatomical variations during high dose rate brachytherapy of cervical cancers- Can replanning be avoided?
HOD Radiation Oncology
Indian Journal of Pathology and Oncology, 2020
View PDFchevron_right
Influence of brachytherapy applicators geometry on dose distribution in cervical cancer
Elżbieta Senkus, Jacek Jassem
Strahlentherapie und Onkologie, 1997
View PDFchevron_right
Interfraction Variation and Dosimetric Changes in Patients With Cervical Cancer Treated With Intracavitary Brachytherapy
Maureen Bojador
Journal of Global Oncology, 2017
View PDFchevron_right
Uncertainties in Assesment of the Vaginal Dose for Intracavitary Brachytherapy of Cervical Cancer using a Tandem-ring Applicator
Richard Pötter
International Journal of Radiation Oncology*Biology*Physics, 2007
View PDFchevron_right
Clinical Investigations A comparison of dose distribution from Manchester-style and Fletcher-style intracavitary brachytherapy applicator systems in cervical cancer
Bishan Basu
Journal of Contemporary Brachytherapy, 2012
View PDFchevron_right
A Pre-optimised Dosimetry System using a Rigid Applicator for Intracavitary Treatment of Cervical Carcinoma
Stewart Tung, To-Wai Leung
Clinical Oncology, 2006
View PDFchevron_right
” Maximum dose” points in cervical and endometrial cancer medium dose rate brachytherapy
Alipasha Meysamie
2009
View PDFchevron_right
Organ at Risk Doses during High Dose Rate Intracavitary Brachytherapy for Cervical Cancer: A Dosimetric Study
JONEETHA JONES
International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 2018
View PDFchevron_right
Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis
yesenia gonzalez
Brachytherapy, 2021
View PDFchevron_right
Dosimetric comparison of intra-cavitary brachytherapy technique with free-hand (intra-cavitary + interstitial) technique in cervical cancer
Arul Ponni
Journal of Contemporary Brachytherapy, 2024
View PDFchevron_right
Impact of “optimized” treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer
Timothy Kinsella
International Journal of Radiation Oncology*Biology*Physics, 1995
View PDFchevron_right
Evaluation of dosimetric impact of inter-application and intra-application variations in fractionated high-dose-rate intra-cavitary brachytherapy of cervical cancer
tanvir pasha
Journal of Contemporary Brachytherapy, 2021
View PDFchevron_right
Point dose variations with time during traditional brachytherapy for cervical carcinoma
Shalom Kalnicki
Medical Dosimetry, 2000
View PDFchevron_right
Interstitial brachytherapy guided intensity modulated radiation therapy (IBGIMRT) in cervical cancer: a dosimetric study
gopishankar natanasabapathi
PubMed, 2009
View PDFchevron_right
Comparison of high-dose-rate intracavitary brachytherapy dosimetry with and without anesthesia in patients with cervical carcinoma
Seema Sharma
Journal of applied clinical medical physics / American College of Medical Physics, 2014
View PDFchevron_right
Evaluation of a 36 Gy elective node irradiation dose in anal cancer
J. Miny
Radiotherapy and Oncology, 2015
View PDFchevron_right
Impact of brachytherapy applicators geometry on dose distribution in gynaecological cancer
Asghar Gadi
JPMA. The Journal of the Pakistan Medical Association, 2016
View PDFchevron_right
Dosimetric Comparison of Tandem and Ovoids vs. Tandem and Ring for Intracavitary Gynecologic Applications
Daphne Levin
Medical Dosimetry, 2008
View PDFchevron_right
Optimizing the dose rate and technique in cervical carcinoma-balancing cases versus complications
Daniel Petereit
International Journal of Radiation Oncology*Biology*Physics, 1994
View PDFchevron_right
Biological effective doses in the intracavitary high dose rate brachytherapy of cervical cancer
Arunkumar Sharma
Journal of Contemporary Brachytherapy, 2011
View PDFchevron_right
Evaluation of quality indices during multifractionated pelvic interstitial brachytherapy for cervical cancer
jamema swamidas
Brachytherapy, 2013
View PDFchevron_right
Comparison of ICRU 38 rectal reference point dose estimates with measured dose in vivo in cobalt-60 HDR brachytherapy for cervical cancer
Marivic Candado
Journal of Radiation Oncology, 2020
View PDFchevron_right
A comparison between revised Manchester Point A and ICRU-89–recommended Point A definition absorbed-dose reporting using CT images in intracavitary brachytherapy for patients with cervical carcinoma
Satyajit Pradhan
Brachytherapy, 2020
View PDFchevron_right